Pentixapharm Holding AG (ETR:PTP)
Germany · Delayed Price · Currency is EUR 1.820
-0.030 (-1.62%)
Last updated: Aug 26, 2026, 2:29 PM CET
Pentixapharm Holding AG Revenue
Pentixapharm Holding AG had revenue of 15.00K EUR in the quarter ending June 30, 2026, a decrease of -91.18%. This brings the company's revenue in the last twelve months to 242.00K, down -86.48% year-over-year. In the year 2025, Pentixapharm Holding AG had annual revenue of 526.00K, down -63.28%.
Revenue (ttm)
242.00K
Revenue Growth
-86.48%
P/S Ratio
186.38
Revenue / Employee
6.37K
Employees
38
Market Cap
45.11M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 526.00K | -906.50K | -63.28% |
| Jan 1, 2025 | 1.43M | -331.50K | -18.79% |
| Dec 31, 2023 | 1.76M | 1.73M | 5,590.32% |
| Dec 31, 2022 | 31.00K | -30.00K | -49.18% |
| Dec 31, 2021 | 61.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Maternus-Kliniken Aktiengesellschaft | 118.03M |
| FamiCord AG | 87.58M |
| DocCheck AG | 55.32M |
| MeVis Medical Solutions AG | 15.48M |